Jin-long Chen - Net Worth and Insider Trading

Jin-long Chen Net Worth

The estimated net worth of Jin-long Chen is at least $1 Million dollars as of 2024-11-13. Jin-long Chen is the Chief Scientific Officer of NGM Biopharmaceuticals Inc and owns about 908,893 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $1 Million. Details can be seen in Jin-long Chen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jin-long Chen has not made any transactions after 2023-01-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jin-long Chen

To

Jin-long Chen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jin-long Chen owns 2 companies in total, including NGM Biopharmaceuticals Inc (NGM) , and Tenaya Therapeutics Inc (TNYA) .

Click here to see the complete history of Jin-long Chen’s form 4 insider trades.

Insider Ownership Summary of Jin-long Chen

Ticker Comapny Transaction Date Type of Owner
NGM NGM Biopharmaceuticals Inc 2023-01-17 director & Chief Scientific Officer
TNYA Tenaya Therapeutics Inc 2021-07-29 director

Jin-long Chen Latest Holdings Summary

Jin-long Chen currently owns a total of 1 stock. Jin-long Chen owns 908,893 shares of NGM Biopharmaceuticals Inc (NGM) as of January 17, 2023, with a value of $1 Million.

Latest Holdings of Jin-long Chen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NGM NGM Biopharmaceuticals Inc 2023-01-17 908,893 1.54 1,399,695

Holding Weightings of Jin-long Chen


Jin-long Chen Form 4 Trading Tracker

According to the SEC Form 4 filings, Jin-long Chen has made a total of 18 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the sale of 85,082 shares on January 17, 2023, which brought Jin-long Chen around $438,172.

Insider Trading History of Jin-long Chen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jin-long Chen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jin-long Chen Ownership Network

Ownership Network List of Jin-long Chen

No Data

Ownership Network Relation of Jin-long Chen

Insider Network Chart

Jin-long Chen Owned Company Details

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

Jin-long Chen is the director & Chief Scientific Officer of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, Jin-long Chen made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

Jin-long Chen Mailing Address

Above is the net worth, insider trading, and ownership report for Jin-long Chen. You might contact Jin-long Chen via mailing address: 630 Gateway Blvd., South San Francisco Ca 94080.